These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7512397)

  • 1. RANTES augments radical oxygen products from eosinophils.
    Chihara J; Hayashi N; Kakazu T; Yamamoto T; Kurachi D; Nakajima S
    Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):52-3. PubMed ID: 7512397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming effect of RANTES on eosinophil oxidative metabolism.
    Chihara J; Yamada H; Yamamoto T; Kurachi D; Hayashi-Kameda N; Honda K; Kayaba H; Urayama O
    Allergy; 1998 Dec; 53(12):1178-82. PubMed ID: 9930594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RANTES augments eosinophil lucigenin-dependent chemiluminescence.
    Chihara J; Kakazu T; Higashimoto I; Saito N; Honda K; Tsuda A; Kayaba H; Kamada Y; Oyamada H; Urayama O
    Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():40-3. PubMed ID: 9758895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophil activation by eotaxin--eotaxin primes the production of reactive oxygen species from eosinophils.
    Honda K; Chihara J
    Allergy; 1999 Dec; 54(12):1262-9. PubMed ID: 10688429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemokine RANTES is more than a chemoattractant: characterization of its effect on human eosinophil oxidative metabolism and morphology in comparison with IL-5 and GM-CSF.
    Kapp A; Zeck-Kapp G; Czech W; Schöpf E
    J Invest Dermatol; 1994 Jun; 102(6):906-14. PubMed ID: 7516398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RANTES is a chemotactic and activating factor for human eosinophils.
    Alam R; Stafford S; Forsythe P; Harrison R; Faubion D; Lett-Brown MA; Grant JA
    J Immunol; 1993 Apr; 150(8 Pt 1):3442-8. PubMed ID: 7682241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the cytokine RANTES released from platelets as an eosinophil chemotactic factor.
    Kameyoshi Y; Schröder JM; Christophers E; Yamamoto S
    Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):49-51. PubMed ID: 7512396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of RANTES on intracellular expression of EG2 antigen in eosinophils.
    Kakazu T; Chihara J; Saito A; Higashimoto I; Yamamoto T; Kurachi D; Nakajima S
    Int Arch Allergy Immunol; 1995; 108 Suppl 1():43-4. PubMed ID: 7549521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of rantes (regulated on activation, normal T expressed and secreted) on eosinophil adhesion to plasma coated glass using eosinophilic cell line (EoL-1)].
    Kakazu T; Chihara J; Saito A; Nakajima S
    Arerugi; 1995 Apr; 44(4):491-7. PubMed ID: 7541195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3.
    Elsner J; Petering H; Höchstetter R; Kimmig D; Wells TN; Kapp A; Proudfoot AE
    Eur J Immunol; 1997 Nov; 27(11):2892-8. PubMed ID: 9394815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adhesion to fibronectin augments eosinophil radical oxygen products.
    Higashimoto I; Chihara J; Kakazu T; Yamamoto T; Kurachi D; Nakajima S
    Int Arch Allergy Immunol; 1995; 108 Suppl 1():48-9. PubMed ID: 7549523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The inhibitory effect of oxatomide on oxygen radical products from human eosinophils and an eosinophilic cell line].
    Chihara J; Yasukawa A; Yamamoto T; Kurachi D; Haraguchi R; Mori T; Seguchi M; Uenishi H; Nakajima S
    Arerugi; 1991 Jul; 40(7):689-94. PubMed ID: 1681796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils.
    Kameyoshi Y; Dörschner A; Mallet AI; Christophers E; Schröder JM
    J Exp Med; 1992 Aug; 176(2):587-92. PubMed ID: 1380064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory action of levocetirizine on the production of eosinophil chemoattractants RANTES and eotaxin in vitro and in vivo.
    Kanei A; Asano K; Kanai K; Furuta A; Sasaki K; Suzaki H
    In Vivo; 2014; 28(4):657-66. PubMed ID: 24982238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of reactive oxygen and nitrogen metabolites on RANTES- and IL-5-induced eosinophil chemotactic activity in vitro.
    Sato E; Simpson KL; Grisham MB; Koyama S; Robbins RA
    Am J Pathol; 1999 Aug; 155(2):591-8. PubMed ID: 10433951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES.
    Ebisawa M; Yamada T; Bickel C; Klunk D; Schleimer RP
    J Immunol; 1994 Sep; 153(5):2153-60. PubMed ID: 7519642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of singlet oxygen by eosinophils activated in vitro by C5a and leukotriene B4.
    Teixeira MM; Cunha FQ; Noronha-Dutra A; Hothersall J
    FEBS Lett; 1999 Jun; 453(3):265-8. PubMed ID: 10405157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human peripheral blood eosinophils express and release interleukin-8.
    Simon HU; Yousefi S; Weber M; Simon D; Hölzer C; Hartung K; Blaser K
    Int Arch Allergy Immunol; 1995; 107(1-3):124-6. PubMed ID: 7542056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of eotaxin on the generationof reactive oxygen species from eosinophil cell line, YY-1.
    Honda K; Yamada Y; Cui C; Saito N; Kayaba H; Kobayashi Y; Oyamada H; Kamada Y; Kuwasaki T; Tsurufuji S; Chihara J
    Int Arch Allergy Immunol; 1999; 120 Suppl 1():48-50. PubMed ID: 10529604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RANTES- and interleukin-8-induced responses in normal human eosinophils: effects of priming with interleukin-5.
    Schweizer RC; Welmers BA; Raaijmakers JA; Zanen P; Lammers JW; Koenderman L
    Blood; 1994 Jun; 83(12):3697-704. PubMed ID: 7515718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.